Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov-Dec;31(6):685-691.
doi: 10.20524/aog.2018.0304. Epub 2018 Aug 6.

Efficacy of bio-optimized extracts of turmeric and essential fennel oil on the quality of life in patients with irritable bowel syndrome

Affiliations

Efficacy of bio-optimized extracts of turmeric and essential fennel oil on the quality of life in patients with irritable bowel syndrome

Agostino Di Ciaula et al. Ann Gastroenterol. 2018 Nov-Dec.

Abstract

Background: The use of herbal products to treat irritable bowel syndrome (IBS), a disease that frequently affects the quality of life (QoL), is still under evaluation. This open pilot study assessed the efficacy of bio-optimized extracts of turmeric and essential fennel oil (Enterofytol®) in IBS patients.

Methods: A total of 211 patients (14% diarrhea-predominant, IBS-D; 24% constipation-predominant, IBS-C; 62% mixed, IBS-M) were enrolled by general practitioners and completed questionnaires measuring symptom severity and QoL before and after Enterofytol®, two capsules b.i.d. for one month, followed by two capsules q.d. for another month.

Results: IBS severity index and QoL were inversely related. A significant reduction in the severity index and an improvement in QoL were evident following treatment in all IBS subgroups. IBS-D patients showed the worst clinical picture at entry, with the highest IBS severity index and the lowest QoL score, compared with IBS-C and IBS-M subtypes. IBS-D patients, however, also showed the most pronounced response to therapy, considering both scores. The improvement in the IBS severity index was independent of age and sex.

Conclusions: Results from this "real-life" study show that the combination of turmeric and essential fennel oil over two months improves both symptoms and QoL in IBS patients, irrespectively of age, sex, initial severity of symptoms and IBS-subtypes, suggesting a potential role for the natural treatment of IBS.

Keywords: Abdominal pain; curcumin; fennel essential oil; irritable bowel syndrome; quality of life; turmeric.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

Figures

Figure 1
Figure 1
Relationship between quality of life score and irritable bowel syndrome (IBS) severity index, at enrollment, in a group of 211 IBS patients
Figure 2
Figure 2
(A) Irritable bowel syndrome (IBS) severity index at entry and after 30 and 60 days of therapy with bio-optimized extracts of turmeric and essential oil of fennel in 211 IBS patients. (B) Progressive decline in the IBS severity index during 60 days of therapy, according to IBS subtype IBS-D, IBS diarrhea-predominant; IBS-C, IBS constipation-predominant; IBS-M, IBS mixed-type.
Figure 3
Figure 3
(A) Irritable bowel syndrome (IBS) quality of life score at entry and after 60 days of therapy with bio-optimized extracts of turmeric and essential oil of fennel in 211 patients with IBS). (B) Variation in the IBS quality of life score during 60 days of therapy, according to IBS subtype IBS-D, IBS diarrhea-predominant; IBS-C, IBS constipation-predominant; IBS-M, IBS mixed-type.

Similar articles

Cited by

References

    1. Portincasa P, Moschetta A, Baldassarre G, Altomare DF, Palasciano G. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol. 2003;9:2293–2299. - PMC - PubMed
    1. Portincasa P, Bonfrate L, Scribano ML, et al. Curcumin and fennel essential oil improve symptoms and quality of life in patients with irritable bowel syndrome. J Gastrointestin Liver Dis. 2016;25:151–157. - PubMed
    1. Portincasa P, Bonfrate L, de Bari O, Lembo A, Ballou S. Irritable bowel syndrome and diet. Gastroenterol Rep (Oxf) 2017;5:11–19. - PMC - PubMed
    1. Zito FP, Polese B, Vozzella L, et al. Good adherence to Mediterranean diet can prevent gastrointestinal symptoms: A survey from Southern Italy. World J Gastrointest Pharmacol Ther. 2016;7:564–571. - PMC - PubMed
    1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491. - PubMed

LinkOut - more resources